LAFAYETTE, Louisiana — Lafayette General Health's research department is seeking male and female pancreatic cancer patients for an observational study on the impact of chemotherapy on their quality of life.
Survey participants must be 18 or older. The Advocate reports (http://bit.ly/11TyhFO ) the study will evaluate the medications Abraxane and Gemcitabine in patients diagnosed with metastatic adenocarcinoma of the pancreas.
The hospital says the objective of the research is to gather information and assess the quality of life in patients who are newly diagnosed before initiation of first-line chemotherapy, or currently treated with certain medications.
Information from: The Advocate, http://theadvocate.com